CD8A and Alzheimer disease: Both CD4+ and CD8+ T cells have the capacity to traverse the blood-brain barrier, thereby gaining entry to the brain and engaging in the modulation of central neuroinflammation, which in turn affects the progression of AD (Jorfi et al., 2023b).